Company registration number 09510084 (England and Wales)
THE BROOK SURGERY PROPERTY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
PAGES FOR FILING WITH REGISTRAR
THE BROOK SURGERY PROPERTY LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
THE BROOK SURGERY PROPERTY LIMITED
BALANCE SHEET
AS AT 31 MAY 2025
31 May 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investment property
3
1,071,688
1,071,688
Current assets
Debtors
4
100
100
Cash at bank and in hand
8,861
8,933
8,961
9,033
Creditors: amounts falling due within one year
5
(252,583)
(253,767)
Net current liabilities
(243,622)
(244,734)
Total assets less current liabilities
828,066
826,954
Creditors: amounts falling due after more than one year
6
(437,688)
(478,423)
Provisions for liabilities
(81,051)
(80,997)
Net assets
309,327
267,534
Capital and reserves
Called up share capital
7
100
100
Non-distributable profits reserve
8
59,844
59,844
Distributable profit and loss reserves
249,383
207,590
Total equity
309,327
267,534

For the financial year ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 12 November 2025 and are signed on its behalf by:
Dr D A Brook
Director
Company registration number 09510084 (England and Wales)
THE BROOK SURGERY PROPERTY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
- 2 -
1
Accounting policies
Company information

The Brook Surgery Property Limited is a private company limited by shares incorporated in England and Wales. The registered office is Lynwood House, 373-375 Station Road, Harrow, Middlesex, HA1 2AW.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

These financial statements have been prepared on the assumption that the company will continue in operational existence for the foreseeable future.

The validity of this assumption depends on the continuing support of the director s, bankers and creditors.

If the company were unable to continue in existence for the foreseeable future, adjustments would be necessary to reduce the balance sheet values of assets to their recoverable amounts, to reclassify fixed assets as current assets and to provide for further liabilities which might arise.

1.3
Turnover

Turnover represents amounts receivable for rent net of VAT.

1.4
Investment property

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value a t the reporting end date. Changes in fair value are recognised in profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

THE BROOK SURGERY PROPERTY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

THE BROOK SURGERY PROPERTY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
3
Investment property
2025
£
Fair value
At 1 June 2024 and 31 May 2025
1,071,688

The directors having suitable market knowledge considered the above valuation to be a fair reflection of the investment property at 3 1 May 2025.

THE BROOK SURGERY PROPERTY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 5 -
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
100
100
5
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
39,922
38,763
Trade creditors
10,201
431
Taxation and social security
13,162
8,953
Other creditors
189,298
205,620
252,583
253,767
6
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
437,688
478,423
Creditors which fall due after five years are payable as follows:
Payable by instalments
282,817
323,372

The bank loan has been secured by way of a fixed and floating charge over all property and assets of the company.

7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
8
Non-distributable profits reserve
2025
2024
£
£
At the beginning and end of the year
59,844
59,844

The non-distributable profits reserve is used to segregate the unrealised profit on investment property.

THE BROOK SURGERY PROPERTY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 6 -
9
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

Rent received
2025
2024
£
£
Other related parties
35,489
35,913

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due to related parties
£
£
Other related parties
179,939
196,361
Other information

Included within Other creditors is an amount of £1,020 (2024: £1,020) due to the directors.

2025-05-31 2024-06-01 false false false 13 November 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Dr D A Brook Dr J H R Brook 09510084 2024-06-01 2025-05-31 09510084 2025-05-31 09510084 2024-05-31 09510084 core:ShareCapital 2025-05-31 09510084 core:ShareCapital 2024-05-31 09510084 core:FurtherSpecificReserve1ComponentTotalEquity 2025-05-31 09510084 core:FurtherSpecificReserve1ComponentTotalEquity 2024-05-31 09510084 core:RetainedEarningsAccumulatedLosses 2025-05-31 09510084 core:RetainedEarningsAccumulatedLosses 2024-05-31 09510084 core:ShareCapitalOrdinaryShareClass1 2025-05-31 09510084 core:ShareCapitalOrdinaryShareClass1 2024-05-31 09510084 bus:Director1 2024-06-01 2025-05-31 09510084 2023-06-01 2024-05-31 09510084 2024-05-31 09510084 core:WithinOneYear 2025-05-31 09510084 core:WithinOneYear 2024-05-31 09510084 core:CurrentFinancialInstruments 2025-05-31 09510084 core:CurrentFinancialInstruments 2024-05-31 09510084 core:Non-currentFinancialInstruments 2025-05-31 09510084 core:Non-currentFinancialInstruments 2024-05-31 09510084 bus:OrdinaryShareClass1 2024-06-01 2025-05-31 09510084 bus:OrdinaryShareClass1 2025-05-31 09510084 bus:OrdinaryShareClass1 2024-05-31 09510084 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 09510084 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 09510084 bus:FRS102 2024-06-01 2025-05-31 09510084 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 09510084 bus:Director2 2024-06-01 2025-05-31 09510084 bus:FullAccounts 2024-06-01 2025-05-31 xbrli:pure xbrli:shares iso4217:GBP